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Objective: To investigate the relationship betweenSEPS1polymorphismandphosphatidylinositol 3-kinase
(PI3K)/Akt signaling pathway in Kashin-Beck disease (KBD) and further explore the pathogenesis of KBD.
Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to
detect SEPS1 -105G>A polymorphism in 232 cases and 331 controls. The protein expressions of PI3K/Akt
signaling molecules in whole blood and chondrocytes were detected by Western blot.
Results: The frequencies of SEPS1 -105G>A genotype AA (21.1% vs 3.0%) and minor allele A (34.1%
vs 16.0%) in KBD are signiﬁcantly higher than those in controls (OR: 8.020, 95% conﬁdence interval (95%
CI) 6.341e10.290, P < 0.0001; OR: 2.470, 95% CI 2.001e4.463, P < 0.0001, respectively). SEPS1 AA ge-
notype was an independent risk factor for KBD (adjusted OR: 9.345, 95% CI 4.254e20.529; P < 0.0001).
The expression of Gbg, PI3Kp110, pAkt and pGSK3b in KBD group were higher than that in control group
(all P < 0.05). Gbg, pAkt and pGSK3b protein expression of AA and GA increased than GG (all P < 0.05).
Cell apoptosis was increasing and molecule expression of PI3K/Akt signaling pathway were up-regulated
in the tert-Butyl hydroperoxide (tBHP)-injured group, the cell apoptosis and expression levels of PI3K/
Akt in Na2SeO3 group were decreased.
Conclusions: The SEPS1 -105G>A is associated with an increased risk of KBD and inﬂuences the
expression of PI3K/Akt signaling pathway in KBD patients. Apoptosis induced by tBHP in chondrocyte
might be mediated via up-regulation of PI3K/Akt, Na2SeO3 has an effect of anti-apoptosis by down-
regulating of PI3K/Akt signaling pathway.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Kashin-Beck disease (KBD) is a chronic, endemic degenerative
osteoarthropathy in China and other countries of Asia which affects
the epiphyseal growth plate and the articular cartilage
commonly1,2. The mainly pathological changes in KBD are chon-
drocyte necrosis and apoptosis3. Although lots of research and in-
vestigations have been done, its etiology and pathogenesis remains
unclear, three hypotheses have been put forward, such as selenium
(Se) deﬁciency in soil and water in the KBD areas, fungal myco-
toxins in stored food, and excess of humic acid in drinkingwater4e6.Y.M. Xiong, School of Public
sity, No. 76 Yanta West Road,
ax: 86-29-82655032.
iong).
ternational. Published by Elsevier LEpidemiological studies have demonstrated Se deﬁciency is a
widespread phenomenon in the KBD areas, and Se supplement
could decrease the KBD prevalence rate, exert an obvious thera-
peutic effect7. Current research data suggest that KBD is a kind of
disease caused by the genetic risk factors and environmental
factors8e10. The differentially expressed genes between KBD and
the normal group have been discovered, mainly involved in
apoptosis, signal transduction, cytokines11,12. Furthermore, the
chondrocyte necrosis mediated by oxidative stress in KBD cartilage
damage has also been reported13.
It is likely that many effects of selenium are mediated through
its role as a constituent of selenium-containing proteins, a main
functional form for Se in vivo. Evidence exists that Selenoprotein S
(SEPS1) has an impact on the immune and inﬂammatory signal
pathways and has a protective effect on oxidation-injured cells.
Recent reports have showed the -105G>A polymorphism of SEPS1
associate with the pro-inﬂammatory cytokines14,15, and is relatedtd. All rights reserved.
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namely the intestinal type of gastric cancer16 and subclinical car-
diovascular disease17. Our previous study had showed associations
between genetic variations in some selenoprotein genes and sus-
ceptibility to KBD8,18. It is suggested that the -105G>A poly-
morphism of SEPS1 might play an important role in KBD.
Apoptosis is one of the common mechanisms which contribute
to cartilage destruction in KBD12. An aspect of apoptosis regulation
is the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway,
which plays an important role in the stimulation of apoptotic
signaling19,20. The PI3K and its downstream Akt kinase are impor-
tant in the processes of cell survival and apoptosis21. Especially,
apoptosis of chondrocytes can be regulated by PI3K/Akt signaling
pathway, which is closely related to the occurrence and develop-
ment of osteoarthritis, suggesting that PI3K/Akt signaling pathway
may be one of the main factors resulting in destruction of articular
cartilage22.
At present, there have been no report on the role of the SEPS1
-105G>A polymorphism in KBD, in particular, study on the rela-
tionship between SEPS1 polymorphism and the PI3K/Akt signal
pathway. Therefore, we conducted a case control study to explore
the associations between KBD risk and SEPS1 -105G>A poly-
morphism, investigated the expression of PI3K/Akt signaling mo-
lecular in KBD patients and evaluated the relationship between
SEPS1 -105G>A and PI3K/Akt signaling pathway. Furthermore, a
cell experiment was performed to explore the role of PI3K/Akt
signaling pathway in tert-Butyl hydroperoxide (tBHP) induced
chondrocytes apoptosis and the pretective effect of Na2SeO3.
Materials and methods
Study population
According to the national diagnosis of KBD (WS/T207-2010,
Ministry of Health, People's Republic of China), KBD was diagnosed
on the base of radiographic examination and clinical diagnosis. 232
KBD patients without osteoarthritis, rheumatoid arthritis, achon-
droplasia, etc were all from six counties in KBD endemic areas
(Xunyi, Linyou, Qianyang, Long, Changwu and Yongshou counties).
331 healthy controls excluded KBD with no arthritis or other joint
diseases were from non-KBD endemic areas in Xi'an of Shaanxi
province. Both groups were frequency matched by age and sex. All
subjects in this study were Han Chinese and resided in Shaanxi
Province, P.R. China. The present study was conducted according to
the guidelines laid down in the Declaration of Helsinki and all
procedures involving human subjects were approved by the Hu-
man Ethics Committee of Xi'an Jiaotong University, People's Re-
public of China, and written informed consent was obtained from
all subjects.
Quantitative real-time PCR
Gene-speciﬁc Primer Sequences for the mRNA of human SEPS1
-105G>A were synthesized by Sangon Biotech (Shanghai, China).
Ampliﬁcation primers were as follows: SEPS1 (forward 50-CACC-
TATGGCTGGTACATCGT-30, and reverse 50-AACAACATCAGGTTCCA-
CAGC-30) and b-actin (forward 50-GAACGGTGAAGGTGACAGCAG-30,
and reverse 50-GTGGACTTGGGAGAGGACTGG-30). RNA was isolated
from 3 ml whole blood from KBD patients and controls using the
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer's instructions, and reverse-transcribed in a thermo-
cycler using the RevertAidTM First Strand complementary DNA
Synthesis Kit (MBI, Fermentas, Vilnius, Lithuania) following the
manufacturer's instructions. Quantiﬁcation of mRNA of SEPS1 was
performed on iQe5 quantitative real-time PCR (qRT-PCR) DetectionSystems (Bio-Rad, Philadelphia, PA, USA) using BioEasy SYBR Green
Real Time PCR Kit (Bioer, Hangzhou, Zhejiang, China). The reactions
were performed in a 25 ml mixture, containing 2 ml complementary
DNA, 0.5 ml each primer (10 mm), 12.5 ml 2 SYBR Mix (with
4.0 mmMg2þ), 0.15 ml Taq DNA polymerase and 9.35 ml ddH2O. The
reaction conditionwas as following: initial denaturation at 94C for
2 min, followed by 40 cycles of denaturation at 94C for 10 s,
annealing at 60C for 15 s and extension at 72C for 30 s. All re-
actions were performed in duplicate. The results were normalized
to the level of b-actin and analyzed by iQe5 software (version 2.0;
Bio-Rad) and SPSS 13.0 software.
Genotyping analysis
DNA was puriﬁed using classical protease K extraction. SNP
-105G>A of the SEPS1 gene was identiﬁed using the polymerase
chain reaction-restriction fragment length polymorphism (PCR-
RFLP). The primers were as follows: forward 50-
CCTCTTGGCGTTCCATGACC-30, and reverse 50-GGGCGACCACT-
GACTTCCTT-30. PCR was carried out using an Eppendorf gradient
type mastercycler (Eppendorf, Germany) with a total volume of
12.5 ml, containing 6.25 ml of 2 Master Mix, 0.5 ml of each primer
(10 mM), 1.5 ml of DNA and 3.75 ml of ddH2O. The optimum reaction
conditions were as follows: initial denaturation at 94C for 3 min,
followed by 35 cycles of denaturation at 94C for 30 s, annealing at
60C for 30 s and extension at 72C for 1 min, and with a ﬁnal
elongation step at 72C for 10 min. The ampliﬁcation products were
digested at 37C overnight with MvaI restriction endonuclease
(Thermo Scientiﬁc Company, USA). Enzyme digested products were
identiﬁed by 1% agarose gel electrophoresis and visualized by a
Light Transilluminator (UVP, Upland, CA, USA). All the primers used
in our studywere synthesized by Sangon Biotech (Shanghai, China).
Genotyping of 20% samples was repeated blind to conﬁrm assay
ﬁdelity.
Western blotting
Trizol method was applied to extract the total protein in whole
blood and cartilage cells. Protein samples were separated with 10%
SDSepolyacrylamide gels. After protein was transferred onto NC
membranes (Millipore Ireland BV, Cork, Ireland), the membranes
were blocked with 5% non-fat dry milk for 1 h, rinsed three times
with TBST for 5 min and then incubated with the primary antibody
(Gbg 1:1000; PI3Kp110 1:1000; pAkt 1:500; pGSK3b 1:500, all from
Santa Cruz, CA, USA) overnight at 4C, rinsed three times with TBST
for 5 min, followed by incubation with the matching horseradish
peroxidase-conjugated IgG antibody (1:10,000, Pierce Company,
WI, USA) for 30 min, then the membrane was again rinsed 3 times
with TBST for 5 min. Blots were developed using enhanced chem-
iluminescence (ECL) and exposure to X-ray ﬁlm. The immunoblots
were visualized and quantiﬁed by gel imaging system (GDS-8000).
Each independent experiment repeated four times.
TBHP induced oxidative damage in C28/I2 human chondrocytes
C28/I2 chondrocytes, a human cell line provided by Dr Mary B.
Goldring from the Cornell University USA, were cultured in DMEM-
Ham's F-12 with a ratio of 1: 1 (v/v) (DMEM/F12; Hyclone, Logan,
UT, USA) containing 12% fetal calf serum (SiJiQing Bio-Technique Co.
Ltd., ZheJiang, China) and PenicillineStreptomycin Solution (100)
at 37C in a humidiﬁed atmosphere with 5% CO2 at 37C. The ex-
periments were divided into control group (C), tBHP injury group
(O, tBHP 300 mmol/L), low Se pre-protection group (OS1, 0.05 mg/mL
Na2SeO3þ 300 mmol/L tBHP), middle Se pre-protection group (OS2,
0.1 mg/mL Na2SeO3 þ 300 mmol/L tBHP) and high Se pre-protection
Table I
Characteristics of the study population
Characteristics KBD (n ¼ 232) Controls (n ¼ 331) P value
Age, x±SD 54.2 ± 5.6 52.3 ± 8.7 0.786*
Sex, female/male 110/132 178/153 0.593y
* The difference of age between KBD and controls was performed using t-test and
no statistical signiﬁcance.
y The frequency of sex between KBD and controls was performed using c2-test
and no statistical signiﬁcance.
Table II
Genotype and allele frequencies of polymorphisms of SEPS1 -105G>A between KBD
and control group*
n Genotype (n, %) Allele (n, %)
GG GA AA G-allele A-allele
KBD 232 123 (53.0) 60 (25.9) 49 (21.1) 306 (65.9) 144 (34.1)
Control 331 235 (71.0) 86 (26.0) 10 (3.0) 556 (84.0) 106 (16.0)
c2 ¼ 49.573, P < 0.0001* c2 ¼ 39.2983, P < 0.0001*
OR 1.00 1.33 8.02 1.00 2.47
95% CI 1.091, 1.879 6.341, 10.290 2.001, 4.643
*represents statistical signiﬁcance at P < 0.05.
OR: odds ratio; 95% CI: 95% conﬁdence interval.
* The comparison of genotype and allele frequency between KBD and controls
was performed using c2-test.
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OS3 were pre-protected with different concentrations of Na2SeO3
for 24 h, then treated with 300 mmol/L tBHP for 24 h, and the
apoptosis of cell was analyzed with Hoechst 33342 staining. Cell
apoptosis was evaluated under a ﬂuorescence microscope and
chondrocytes that showed clear condensation and small bright
nucleus were counted as apoptotic cells.
Statistical analysis
The normality of the distribution was analyzed using the Kol-
mogoroveSmirnov test. Quantitative data were expressed as
mean ± standard deviation (SD). Differences in measurement data
without skewness between control and KBD patients were assessed
by two tailed Student t test. Categorical variables were presented
using frequency counts and compared by c2-test. The c2 goodness-
of-ﬁt test was used to identify signiﬁcant departures from the
HardyeWeinberg equilibrium. Odds ratio (OR) and 95% conﬁdence
interval (CI) were calculated to measure the relative risks of KBD.
Unconditional logistic regression analysis was used to adjust for the
matching variables as covariates. a¼ 0.05was set up as a signiﬁcant
level. All statistical analyses were performed with the SPSS 13.0
(SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics of study population
A total of 232 KBD patients and 331 healthy controls with fre-
quency matched by age and sex were included in this study. No
statistically signiﬁcant difference was found between the cases and
controls in age (54.2 ± 5.6 vs 52.3 ± 8.7, P ¼ 0.786) and sex (male/
female, 110/132 vs 178/153, P ¼ 0.593). The baseline characteristics
of the two groups are shown in Table I.
The mRNA expression of SEPS1 in whole blood
SEPS1 mRNA level in whole blood was determined by qRT-PCR
(n ¼ 10 in each group), and b-actin cDNA was the reference in all
experiments. Results showed mRNA expression of SEPS1 in whole
blood was no difference between KBD and control groups
(P ¼ 0.164).
SEPS1 -105G>A genotype analysis
The frequency of SEPS1 -105G>A polymorphism in the controls
and KBD patients did not deviate from those expected under the
HardyeWeinberg equilibrium (P ¼ 0.979, 0.949, respectively),
suggesting samples selected can be representative of population.
The distribution of genotypes and alleles of SEPS1 -105G>A in the
two groups were shown in Table II. In the KBD group, the fre-
quencies of GG, GA and AA genotypes for the -105G>A were 53%,
25.9% and 21.1%, respectively, while in the control group, the fre-
quencies were 71.0%, 26.0% and 3.0%, respectively. Accordingly, G-
allele and A-allele frequency in KBD were 65.9% and 34.1% and that
in control group were 84% and 16%, respectively. c2-Test results
displayed that the SEPS1 -105G>A were statistically signiﬁcant
differences in genotypic and allelic frequency between the KBD and
control groups (P < 0.0001). The genotypes AA and minor allele A
had a higher proportion in KBD group than control group and were
associated with an increased risk for KBD (OR: 8.02, 95% CI
6.341e10.290; OR: 2.470, 95% CI 2.001e4.463, respectively). In or-
der to promote the effectiveness of analysis, an unconditional lo-
gistic regression analysis was conducted, which revealed that
SEPS1 AA genotype was an independent risk factor for KBD(adjusted OR 9.345, 95% CI 4.254~20.529; P < 0.0001). These data
suggested that SEPS1 -105G>A polymorphism had a statistically
signiﬁcant association with KBD risk.
Association of SEPS1 genetic variants with PI3K/Akt signaling
pathway
The protein expression levels of PI3K/Akt signaling pathway in
whole blood from 20 KBD patients and 20 healthy controls were
detected by Western blot. Results showed the expression levels of
Gbg, PI3Kp110, pAkt and pGSK3b proteins in KBD groupwere higher
than that in control group (11.589-, 1.964-, 2.243- and 2.841-fold,
respectively) (Fig. 1) and the difference was statistically signiﬁcant
(P< 0.0001, P¼ 0.023, P¼ 0.019, P¼ 0.008, respectively), suggesting
PI3K/Akt signaling pathway is up-regulated in KBD patients.
In order to study the association between SEPS1 -105G>Avariant
and PI3K/Akt signaling pathway, a genotype subgroup analysis was
carried out. A total of 15blood sampleswere randomly selected from
wild-type (GG), heterozygote (AG) and variant genotype (AA),
respectively. The genotype subgroup analysis towards Gbg,
PI3Kp110, pAkt and pGSK3b proteins expression was detected by
Western blot. Results showed strong evidence for association be-
tween SEPS1 -105G>A polymorphism and PI3K/Akt signaling
pathway: Compared with GG, Gbg protein expression levels of AA
and GA increased 1.87- and 1.48-fold (P ¼ 0.004, P ¼ 0.038, respec-
tively), pAkt protein expression levels of AA and GA increased 3.68-
and 1.74-fold (P< 0.0001, P¼ 0.013, respectively). Similarly, pGSK3b
protein expression levels of AA andGAwere higher than those of GG
(2.49- and 1.44-fold, P¼ 0.002, P¼ 0.036, respectively). In addition,
there were no differences of PI3Kp110 protein expression level
among the three kinds of genotypes (P ¼ 0.079) (Fig. 2). Results
showed that Gbg, pAkt and pGSK3b protein expression levels were
up-regulated in the variant genotype (AA) individual, suggesting
SEPS1 -105G>A polymorphism might be associated with the up-
regulation of PI3K/Akt signaling pathway.
Alternation of PI3K/Akt signaling pathway in tBHP induced
chondrocytes apoptosis and the protective effect of Na2SeO3
Cellular apoptosis induced by tBHP was observed by Hoechst
33,342 staining (Fig. 3). Figure 3 showed the chondrocyte apoptosis
Fig. 1. Proteins expression of Gbg, PI3Kp110, pAkt and pGSK3b in whole blood be-
tween the KBD patients and controls. (A) The expression levels of Gbg, PI3Kp110, pAkt
and pGSK3b by Western blot. (B) The relative proteins expression levels of Gbg,
PI3Kp110, pAkt and pGSK3b quantitated by densitometric analysis were representative
of four repeated experiments. All protein expression levels in KBD group were
signiﬁcantly higher than that in control group (P < 0.0001, P ¼ 0.023, P ¼ 0.019,
P ¼ 0.008, respectively). K1, K2, and K3: samples from KBD patients; N1, N2, and N3:
samples from control subjects. *represents signiﬁcance at P < 0.05.
**represent signiﬁcance at P < 0.01.
Fig. 2. The proteins expression of Gbg, PI3Kp110, pAkt and pGSK3b in whole blood in
genotype subgroup. (A) The expression levels of Gbg, PI3Kp110, pAkt and pGSK3b by
Western blot. Each 15 samples were randomly selected from wild-type (GG), hetero-
zygote (GA) and variant genotype (AA) subgroup, respectively. (B) The relative proteins
expression levels of Gbg, PI3Kp110, pAkt and pGSK3b in three subgroup quantitated by
densitometric analysis were representative of four repeated experiments. Compared
with wild-type (GG), Gbg, pAkt and pGSK3b protein expression levels of variant ge-
notype (AA) and heterozygote (GA) increased signiﬁcantly. In addition, there were no
signiﬁcant differences of PI3Kp110 protein expression level among the three kinds of
genotypes. *represents signiﬁcance at P < 0.05. **represent signiﬁcance at P < 0.01.
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different Na2SeO3 concentration in C28/I2 cells. Compared with the
control group, apoptotic nucleus was obviously increased in tBHP
injury group. After pre-treatment with different concentration of
Na2SeO3 for 24 h, apoptotic nucleus was decreased in three Se
treatment groups. Middle Se pre-protection group (0.1 mg/mL
Na2SeO3) exhibited the lowest apoptotic nucleus number among
the three groups. Our results indicated that tBHP injury could
induce apoptosis while Na2SeO3 could reduce apoptosis in
chondrocytes.
In order to study the inﬂuence of Na2SeO3 on PI3K/Akt signaling
pathway in oxidative damaged C-28/I2 cells, Gbg, PI3Kp110, pAkt
and pGSK3b protein expressions in C-28/I2 cartilage cells were
detected by Western blot. As shown in Fig. 4, the expression levels
of Gbg, PI3Kp110, pAkt and pGSK3b protein in the tBHP injury
group increased compared with the control group (P ¼ 0.029,
P ¼ 0.012, P ¼ 0.005, P ¼ 0.037, respectively). Compared with the
tBHP injury group, the expression levels of Gbg, PI3Kp110 and pAkt
protein in three Na2SeO3 group showed a down-regulated trend, in
particular, the expression levels in the middle Se pre-protection
group signiﬁcantly decreased (P ¼ 0.024, P ¼ 0.015, P < 0.0001,
respectively). The expression levels of pGSK3b protein were
decreased remarkably in low and middle Se pre-protection group
(P ¼ 0.048, P ¼ 0.034, respectively). The results showed that cell
apoptosis was increasing and protein expression levels of PI3K/Akt
signaling molecule were up-regulated when oxidative stressoccurred in chondrocytes, while treatment with Na2SeO3 could
decrease the cell apoptosis and down-regulate the protein
expression levels of PI3K/Akt signaling molecule, suggesting that
Na2SeO3 could minimize oxidative damage to chondrocytes by
down-regulating the expression of PI3K/Akt signaling pathway.Discussion
It is believed that genetic factors as well as environmental Se
deﬁciency underlie the pathogenesis of KBD. SEPS1 has been clas-
siﬁed as a new ER membrane protein with antioxidant function.
Especially one promoter variant, SEPS1-105G>A has a role in
mediating inﬂammation that is characterized by increased release
of inﬂammatory cytokines, such as IL-1b, IL-26 and TNF-a14. KBD is
an endemic chronic osteochondropathy, and excessive oxidative
stress and inﬂammation may be involved in the pathogenesis of
KBD23,24, but little is known whether SEPS1 -105G>A genetic var-
iations play a role in the development of KBD. To clarify the rela-
tionship between SEPS1 -105G>A variant and KBD risk, we
conducted a case control study to investigate SEPS1 -105G>A
polymorphisms in KBD population. Results showed the distribution
of AA genotype and A-allele frequencies were signiﬁcantly higher
in KBD patients than that in controls. An increased risk of KBD was
observed in AA genotype compared with GG wild-type, accord-
ingly, A-allele of the SEPS1 -105G>A carriers had increased risk of
KBD. These data suggested that SEPS1 -105G>A variant has a sta-
tistically signiﬁcant association with KBD risk. The allele frequency
(C vs T) for SEPS1 -105G>A (rs28665122) was searched on http://
Fig. 3. The apoptosis of C28/I2 human chondrocytes detected by Hoechst33342 staining test. Cells were treated as described in methods. tBHP injury obviously increased apoptosis of
C28/I2 chondrocytes while pretreatment with Na2SeO3 reduced apoptosis. C: Control group. O: tBHP injury group (tBHP300 mmol/L). OS1: low Se pre-protection group (0.05 mg/mL
Na2SeO3þ300mmol/L tBHP). OS2:middle Se pre-protection group (0.1mg/mLNa2SeO3þ300mmol/L tBHP). OS3: high Se pre-protection group (0.15mg/mLNa2SeO3þ300mmol/L tBHP).
Fig. 4. The protein expression of Gbg, PI3Kp110, pAkt and pGSK3b in C-28/I2 cells
using Western blots. The expression levels of Gbg, PI3Kp110, pAkt and pGSK3b protein
in the O group increased compared with the C group (P ¼ 0.029, P ¼ 0.012, P ¼ 0.005,
P ¼ 0.037, respectively). Compared with the O group, the expression levels of Gbg,
PI3Kp110 and pAkt protein in three Na2SeO3 group showed a downward trend, in
particular, the expression levels in OS2 group signiﬁcantly decreased (P ¼ 0.024,
P ¼ 0.015, P < 0.0001, respectively). The protein expression levels of pGSK3b in OS1 and
OS2 group decreased signiﬁcantly (P ¼ 0.048, P ¼ 0.034, respectively). The 0.1 mg/mL
Na2SeO3 is probably the most suitable concentration of Se protection. C: control group.
O: tBHP injury group (tBHP300 mmol/L). OS1: low Se pre-protection group (0.05 mg/mL
Na2SeO3 þ 300 mmol/L tBHP). OS2: middle Se pre-protection group (0.1 mg/mL
Na2SeO3 þ 300 mmol/L tBHP). OS3: high Se pre-protection group (0.15 mg/mL
Na2SeO3 þ 300 mmol/L tBHP).
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Japanese (0.938, 0.062), European (0.860, 0.140) and African (0.469,
0.531). The allele frequencies for rs28665122 in the control group is
similar to Han Chinese, suggesting that this frequency distribution
is consistent with the Han Chinese population.
PI3K/Akt is the primary signaling pathway of chondrocyte
survival and apoptosis, which is the core hub for transferring
external signal25. Our results showed that the expression levels of
PI3Kp110, pAkt and pGSK3b proteins in KBD group were higher
than that in control group, in addition, Gbg protein, upstream
molecule of PI3K/Akt signaling pathway, elevated than normal. All
these indicated that PI3K/Akt signaling pathway was up-regulated
in KBD patients. Recent studies have found that Akt activationsensitizes cells to reactive oxygen species (ROS)-triggered
apoptosis by elevating ROS levels26. Los M et al.27 also reported
that Akt activation can increase intracellular oxygen consumption
and ROS production, resulting in ROS sensitive cells apoptosis. In
addition, some ﬁnding revealed a function of Akt in the up-
regulation of actinomycin D-induced p53 expression28 and p53
participates in the induction of apoptosis by promoting ROS pro-
duction29. Our previous study also demonstrated that p53 levels
are higher in whole blood samples of KBD patients8. Thus, it is
speculated that activation of PI3K/Akt signaling pathway has a role
in chondrocytes apoptosis and necrosis in KBD.
To further study the relationship between SEPS1 -105G>A
polymorphism and up-regulation of PI3K/Akt signaling pathway in
KBD patients, a SEPS1 -105G>A genotype subgroup analyses were
performed. The results showed that Gbg, pAkt and pGSK3b protein
expression levels were up-regulated in the variant genotype (AA)
than that of wild-type (GG) and heterozygote (GA) individual. Our
data indicated that SEPS1 -105G>A might be a functional variant
and the -105G>A was associated with up-regulation of PI3K/Akt
signaling pathway. Handy DE30 also found that knockdown of GPx-
1 gene augmented EGFR-mediated Akt activation, suggesting a role
for selenoprotein gene in modulating this signaling pathway. We
demonstrated here SEPS1 -105G>A polymorphism had an impor-
tant association in alternation of PI3K/Akt signaling pathway, but it
is unclear how the -105G>A polymorphism impacts on PI3K/Akt
signaling pathway. Further studies are needed to better understand
how PI3K/Akt is regulated by the -105G>A polymorphism in KBD
etiology and pathogenesis.
In order to further understand the role of PI3K/Akt signaling
pathway in tBHP induced chondrocyte apoptosis and the protec-
tive effect of Na2SeO3, an experiment of chondrocyte culture was
conducted. Results indicated that tBHP could induce excessive
oxidative stress, leading to chondrocytes apoptosis. The protein
expression levels of Gbg, PI3Kp110, pAkt and pGSK3b in tBHP
injury group were higher than that in control group, in accordance
with the ﬁnding in KBD population; Four kinds of protein
expression levels above in low and middle Se protection group
were obviously down-regulated than that in tBHP-injured group,
X.A. Du et al. / Osteoarthritis and Cartilage 23 (2015) 210e216 215suggesting that oxidative damage could lead to up-regulation of
PI3K/Akt signaling pathway, while Na2SeO3 supplement could
down-regulate the expression levels of PI3K/Akt and minimize
oxidative damage. Evidences indicated that Na2SeO3 has cyto-
protective action through the anti-oxidative damage31 and can
decrease the phosphorylation of Akt32. We also found that the
phosphorylation of Akt and its downstream GSK3b were
decreased in Se protection groups. Therefore, Na2SeO3 exert its
anti-apoptosis effect to protect the cartilage cells from oxidative
stress injury by down-regulating the expression of PI3K/Akt
signaling pathway.
Although we obtained some important results in this study,
some major limitations still existed. Our results suggested that the
genetic association between SEPS1 -105G>A polymorphism and
KBD risk is statistically signiﬁcant, but it is lack of independent
replication and sample size is relatively small. We will replicate our
study in another independent cohort with larger sample size to
verify the conclusions. In addition, we will detect other SNPs of the
SEPS1.
In summary, SEPS1 -105G>A is associated with the risk of
development of KBD in the Chinese population, and this poly-
morphism could inﬂuence the expression of PI3K/Akt signaling
pathway in KBD patients. Furthermore, chondrocyte apoptosis
induced by oxidative stress might be mediated via up-regulation of
PI3K/Akt, and Se has an effect of anti-apoptosis by the down-
regulating of PI3K/Akt signaling pathway. Our results provideAppendixnew insight into the pathogenesis of KBD, and may be of thera-
peutic value for KBD.
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